Clinical Trial Update: Vaccination Against MSI Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating a vaccine targeting microsatellite instability in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MSI-colorectal cancer vaccine

Snippet

Sponsor: Oryx GmbH & Co. KG | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED